Movement Alert|Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings

Market Focus
07/28

On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's better-than-expected second-quarter earnings report.

GlaxoSmithKline reported adjusted earnings per share of 50.5 pence, significantly exceeding the market consensus estimate of 46.8 pence. The company also announced plans to fully achieve annual cost savings of GBP 1.9 billion by 2029, further boosting investor confidence in sector-wide profitability. The strong results triggered a rally across major pharmaceutical names, with GlaxoSmithKline up 5.62%, Merck up 2.82%, Eli Lilly up 2.53%, Johnson & Johnson up 2.45%, and AstraZeneca up 2.15%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10